About Enhancer

Enhancer ID: E_01_0525
Species: human
Position : chr10:88951288-88953288
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Obesity, diabetes, hypertension, atherosclerosis, cancer
Pubmed ID:  29720835
Enhancer experiment: MTS?PMS assay,Oil Red O staining,Immunocytochemistry,
Enhancer experiment description: PE and GE efficiently inhibited adipocyte differentiation by suppressing the expression of adipogenic transcription factor CEBP-? and PPAR-?.PE and GE significantly decreased the expression of adipogenic enzyme FAS.PE and GE increased the expression of lipid degrading enzyme HSL.Mixture of PE and GE exhibited additive or moderately synergistic effect on adipocyte differentiation and lipid accumulation.

About Target gene

Target gene : --
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: PE and GE efficiently inhibited adipocyte differentiation by suppressing the expression of adipogenic transcription factor CEBP-? and PPAR-?.PE and GE significantly decreased the expression of adipogenic enzyme FAS.PE and GE increased the expression of lipid degrading enzyme HSL.Mixture of PE and GE exhibited additive or moderately synergistic effect on adipocyte differentiation and lipid accumulation.

About TF

TF name : FAS
TF experiment: MTS?PMS assay,Oil Red O staining,Immunocytochemistry,
TF experiment description: PE and GE efficiently inhibited adipocyte differentiation by suppressing the expression of adipogenic transcription factor CEBP-? and PPAR-?.PE and GE significantly decreased the expression of adipogenic enzyme FAS.PE and GE increased the expression of lipid degrading enzyme HSL.Mixture of PE and GE exhibited additive or moderately synergistic effect on adipocyte differentiation and lipid accumulation.

About Function

Enhancer function : PE and GE efficiently inhibited adipocyte differentiation by suppressing the expression of adipogenic transcription factor CEBP-? and PPAR-?.PE and GE significantly decreased the expression of adipogenic enzyme FAS.PE and GE increased the expression of lipid degrading enzyme HSL.Mixture of PE and GE exhibited additive or moderately synergistic effect on adipocyte differentiation and lipid accumulation.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
PE and GE efficiently inhibited adipocyte differentiation by suppressing the expression of adipogenic transcription factor CEBP-? and PPAR-?.PE and GE significantly decreased the expression of adipogenic enzyme FAS.PE and GE increased the expression of lipid degrading enzyme HSL.Mixture of PE and GE exhibited additive or moderately synergistic effect on adipocyte differentiation and lipid accumulation.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
FAS Apoptosis signaling pathway panther 104
FAS CASP8 activity is inhibited reactome 11
FAS Caspase Cascade in Apoptosis pid 57
FAS Dimerization of procaspase-8 reactome 11
FAS Direct p53 effectors pid 141
FAS FAS (CD95) signaling pathway pid 36
FAS Fas signaling pathway ( Fas signaling pathway ) inoh 21
FAS FAS signaling pathway panther 37
FAS FasL/ CD95L signaling reactome 5
FAS HIV-1 Nef: Negative effector of Fas and TNF-alpha pid 33
FAS Ligand-dependent caspase activation reactome 16
FAS p73 transcription factor network pid 80
FAS Regulation by c-FLIP reactome 11
FAS RIPK1-mediated regulated necrosis reactome 16
FAS TP53 Regulates Transcription of Death Receptors and Ligands reactome 12
FAS Validated transcriptional targets of TAp63 isoforms pid 54
FAS MAPK signaling pathway kegg 264
FAS Cytokine-cytokine receptor interaction kegg 213
FAS p53 signaling pathway kegg 66
FAS Apoptosis kegg 88
FAS Natural killer cell mediated cytotoxicity kegg 125
FAS Type I diabetes mellitus kegg 42
FAS Alzheimer's disease kegg 167
FAS Chagas disease kegg 103
FAS Pathways in cancer kegg 321
FAS Autoimmune thyroid disease kegg 52
FAS Allograft rejection kegg 37
FAS Graft-versus-host disease kegg 33
FAS Hs_MAPK_Signaling_Pathway_WP382_79951 wikipathways 58
FAS Hs_Apoptosis_WP254_88977 wikipathways 31
FAS Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 wikipathways 122
FAS Hs_Apoptosis_Modulation_and_Signaling_WP1772_91293 wikipathways 71
FAS Hs_Apoptosis_Modulation_by_HSP70_WP384_67054 wikipathways 10
FAS Hs_Allograft_Rejection_WP2328_90020 wikipathways 12
FAS Hs_Nanomaterial_induced_apoptosis_WP2507_89231 wikipathways 8

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs